Paper Details

  1. Home
  2. Paper Details

Pharmacotherapy of obesity - state of the art.

Author: Matyjaszek-MatuszekBeata, PoradaDominik, SzafraniecAneta

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This paper discusses the potential of modern pharmacotherapy in the treatment of obesity. Currently available drugs for weight loss include phentermine, orlistat, lorcaserin, and liraglutide, as well as compounded preparations such as phentermine/topiramate and naltrexone SR/bupropion SR. Some diabetes medications, such as metformin, SGLT2 inhibitors, GLP-1 agonists, and pramlintide, also promote weight loss. The paper emphasizes the need for intensive prevention and treatment of obesity, as well as the development of new pharmacotherapies for effective and safe long-term weight management.
Paper Details　
Original Abstract of the Article :
Obesity, which affects about 13% of the world population, results in significant deterioration of health and serious clinical, mainly meta-bolic and cardiovascular complications. Although the basis of therapeutic treatment is behavioural treatment, often non-pharmacological effects do not produce th...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.5603/EP.2018.0048

データ提供：米国国立医学図書館（NLM）

Obesity: A Multifaceted Challenge

Obesity is a global health concern that plagues millions, making it feel like a vast, unending desert. This study provides an in-depth overview of the current state of pharmacotherapy for obesity, exploring the various drug options and their effectiveness.

Pharmacotherapy: A Tool in the Fight Against Obesity

The study highlights several medications approved for obesity treatment, including phentermine, orlistat, lorcaserin, liraglutide, and combination drugs. These medications work by targeting various aspects of appetite, fat absorption, and metabolism, like guiding a lost camel towards a watering hole. The study emphasizes the need for personalized therapy, considering the individual's needs and potential side effects.

Weight Loss: A Journey of Lifestyle Changes

While medication can be helpful, the study emphasizes the importance of lifestyle changes, such as diet, exercise, and behavioral therapy. These changes, like a steady camel caravan navigating a desert, are essential for achieving sustainable weight loss and improving overall health.

Dr.Camel's Conclusion

Obesity is a complex condition with a multitude of causes, requiring a multifaceted approach. While pharmacotherapy can be a helpful tool in the fight against obesity, it is crucial to recognize that lifestyle changes are essential for long-term success. This study provides a comprehensive overview of the current state of pharmacotherapy for obesity, offering hope for those seeking better treatment options and emphasizing the importance of a holistic approach to weight management.

Date :
  1. Date Completed 2018-12-31
  2. Date Revised 2018-12-31
Further Info :

Pubmed ID

30209803

DOI: Digital Object Identifier

10.5603/EP.2018.0048

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.